Next Article in Journal
Differential Proteome Analysis of Extracellular Vesicles from Breast Cancer Cell Lines by Chaperone Affinity Enrichment
Next Article in Special Issue
Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes
Previous Article in Journal
Interaction of Recombinant Gallus gallus SEPT5 and Brain Proteins of H5N1-Avian Influenza Virus-Infected Chickens
Previous Article in Special Issue
Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD)
Open AccessArticle

Performance of a Multiplex Serological Helicobacter pylori Assay on a Novel Microfluidic Assay Platform

NMI Natural and Medical Sciences Institute at the University of Tuebingen, Markwiesenstr 55, 72770 Reutlingen, Germany
MyCartis, Technologiepark 4, 9052 Zwijnaarde, Belgium
Institut für medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Trogerstrasse 30, 81675 Munich, Germany
UMR 5086 Molecular Microbiology and Structural Biochemistry, CNRS-Université de Lyon 1, Institut de Biologie et Chimie des Protéines, 7 Passage du Vercors, 69367 Lyon Cedex 07, France
Author to whom correspondence should be addressed.
Proteomes 2017, 5(4), 24;
Received: 29 August 2017 / Revised: 19 September 2017 / Accepted: 29 September 2017 / Published: 3 October 2017
(This article belongs to the Special Issue Proteomic Biomarkers in Human Diseases)
Infection with Helicobacter pylori (H. pylori) occurs in 50% of the world population, and is associated with the development of ulcer and gastric cancer. Serological diagnostic tests indicate an H. pylori infection by detecting antibodies directed against H. pylori proteins. In addition to line blots, multiplex assay platforms provide smart solutions for the simultaneous analysis of antibody responses towards several H. pylori proteins. We used seven H. pylori proteins (FliD, gGT, GroEL, HpaA, CagA, VacA, and HP0231) and an H. pylori lysate for the development of a multiplex serological assay on a novel microfluidic platform. The reaction limited binding regime in the microfluidic channels allows for a short incubation time of 35 min. The developed assay showed very high sensitivity (99%) and specificity (100%). Besides sensitivity and specificity, the technical validation (intra-assay CV = 3.7 ± 1.2% and inter-assay CV = 5.5 ± 1.2%) demonstrates that our assay is also a robust tool for the analysis of the H. pylori-specific antibody response. The integration of the virulence factors CagA and VacA allow for the assessment of the risk for gastric cancer development. The short assay time and the performance of the platform shows the potential for implementation of such assays in a clinical setting. View Full-Text
Keywords: Helicobacter pylori; microfluidic; multiplex serology; Evalution™; FliD Helicobacter pylori; microfluidic; multiplex serology; Evalution™; FliD
Show Figures

Figure 1

MDPI and ACS Style

Filomena, A.; Guenther, A.; Planatscher, H.; Topin, F.; She, J.; Formichella, L.; Terradot, L.; Gerhard, M.; Joos, T.O.; Meyer, H.; Schneiderhan-Marra, N. Performance of a Multiplex Serological Helicobacter pylori Assay on a Novel Microfluidic Assay Platform. Proteomes 2017, 5, 24.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop